ArticleJournal of clinical medicine2023

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.

Dolores Isla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.